| Triumph Agility Care, Llc | |
|
3385 Airways Blvd Ste 219, Memphis, TN 38116-3808 | |
| (601) 540-4386 | |
| Not Available |
| Full Name | Triumph Agility Care, Llc |
|---|---|
| Type | Facility |
| Speciality | Nurse Practitioner - Family |
| Location | 3385 Airways Blvd Ste 219, Memphis, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033832514 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | (* (Not Available)) | Primary |
| Provider Name | Tanya K Mccaskill |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1396383238 PECOS PAC ID: 8123216892 Enrollment ID: I20221102001622 |
News Archive
Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® (decitabine) for Injection to treat patients with myelodysplastic syndromes (MDS), a group of bone marrow diseases that alter the production of functional blood cells.
The saying goes, "You can't believe everything you find on the Internet." As simple as that sounds, navigating social media can often blur the line between reality and fantasy. This proves especially difficult when trying to fight a global pandemic.
After one year, a low-calorie, low-fat diet appears more beneficial to dieters' mood than a low-carbohydrate plan with the same number of calories, according to a report in the November 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
A team of researchers in Europe has created a comprehensive data resource to help improve understanding of how coronavirus disease 2019 (COVID-19) progresses and how biomarkers could be used to guide treatment approaches and disease monitoring.
Heart surgeons don't have to choose between taking a coronary-bypass patient off the popular anti-clotting drug clopidogrel (Plavix) after off-pump heart bypass surgery or having the patient bleed excessively in the days following surgery, according to a new study by researchers at Jefferson Medical College.
› Verified 8 days ago
| Provider Name | Tammara Jackson |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1255981296 PECOS PAC ID: 3072980911 Enrollment ID: I20221104001436 |
News Archive
Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® (decitabine) for Injection to treat patients with myelodysplastic syndromes (MDS), a group of bone marrow diseases that alter the production of functional blood cells.
The saying goes, "You can't believe everything you find on the Internet." As simple as that sounds, navigating social media can often blur the line between reality and fantasy. This proves especially difficult when trying to fight a global pandemic.
After one year, a low-calorie, low-fat diet appears more beneficial to dieters' mood than a low-carbohydrate plan with the same number of calories, according to a report in the November 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
A team of researchers in Europe has created a comprehensive data resource to help improve understanding of how coronavirus disease 2019 (COVID-19) progresses and how biomarkers could be used to guide treatment approaches and disease monitoring.
Heart surgeons don't have to choose between taking a coronary-bypass patient off the popular anti-clotting drug clopidogrel (Plavix) after off-pump heart bypass surgery or having the patient bleed excessively in the days following surgery, according to a new study by researchers at Jefferson Medical College.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Triumph Agility Care, Llc 1364 Ashley Cv, Southaven, MS 38671-6426 Ph: (601) 540-4386 | Triumph Agility Care, Llc 3385 Airways Blvd Ste 219, Memphis, TN 38116-3808 Ph: (601) 540-4386 |
News Archive
Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® (decitabine) for Injection to treat patients with myelodysplastic syndromes (MDS), a group of bone marrow diseases that alter the production of functional blood cells.
The saying goes, "You can't believe everything you find on the Internet." As simple as that sounds, navigating social media can often blur the line between reality and fantasy. This proves especially difficult when trying to fight a global pandemic.
After one year, a low-calorie, low-fat diet appears more beneficial to dieters' mood than a low-carbohydrate plan with the same number of calories, according to a report in the November 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
A team of researchers in Europe has created a comprehensive data resource to help improve understanding of how coronavirus disease 2019 (COVID-19) progresses and how biomarkers could be used to guide treatment approaches and disease monitoring.
Heart surgeons don't have to choose between taking a coronary-bypass patient off the popular anti-clotting drug clopidogrel (Plavix) after off-pump heart bypass surgery or having the patient bleed excessively in the days following surgery, according to a new study by researchers at Jefferson Medical College.
› Verified 8 days ago